Replies to post #245665 on Biotech Values

[DewDiligence]

PYXS acquires APGN @$0.64/sh in stock—a 60% premium to yesterday’s close:

https://finance.yahoo.com/news/pyxis-oncology-acquire-apexigen-104500469.html

The deal value is a paltry $16M.